Analysis of different risk factors of hospitalized COVID-19 patients from North-Eastern Bangladesh

Background: In Bangladesh, fighting with the delta sub variety of SARS-CoV-2 was most difficult than its previous and following waves. The aim of this study is to shed light upon different risk factors of COVID-19 and their influences across age-groups inpatients in North-Eastern Districts. Methods: In this case control study, we included 75 positive and 24 negative patients admitted to Jalalabad Ragib Rabeya Medical College and Hospital, Sylhet, Bangladesh from 1st August to 30th September 2021. Different demographic, clinical and radiographic data were collected, analyzed, and compared between/among patients to assess diseases severity. Results: On average patients with COVID-19 were more likely to display remarkably 4, 1.3, and 1.5 times higher serum D-dimer, C-reactive protein, and ferritin level compared to non-COVID-19 people. Higher number of elderly inpatients from the age of 40; specially 60 years and older accounted for the abnormal rise of the aforesaid biochemical risk factors. This age range was also concerning for intensive care unit admission and multiple biomarker elevation. Nevertheless, the percentage of hospitalized COVID-19 patients with hypertension and diabetes is calculated 45% and 30.3%. Alarmingly, 96% of our patients showed COVID-19 assisted lung abnormalities diagnosed by computerized tomography scan and hither the order for degree of damage was bilateral consolidation>ground-glass opacity>pulmonary lesion>chronic obstructive pulmonary disease>cardiomegaly. Conclusions: Age is the principle demographic risk factor of COVID-19, and it has positive correlation with different hospital outcomes, biochemical risk factors, abnormal radiographic manifestations and comorbidities.

[1]  A. Sufian,et al.  Impact of COVID-19 pandemic on tourism geographies of Bangladesh: study on Sylhet region , 2022, GeoJournal.

[2]  Mohammed Hasan Mukhtar,et al.  Elucidating the Correlation of D-Dimer Levels with COVID-19 Severity: A Scoping Review , 2022, Anemia.

[3]  Z. Shankayi,et al.  Cardiomegaly found in hospitalized patients with novel coronavirus disease (COVID-19) , 2022, new microbes and new infections.

[4]  Minghuan Wang,et al.  Age-Related Risk Factors and Complications of Patients With COVID-19: A Population-Based Retrospective Study , 2022, Frontiers in Medicine.

[5]  L. Sukrisman,et al.  Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital , 2021, The Journal of international medical research.

[6]  M. Idzko,et al.  Impact of persistent D-dimer elevation following recovery from COVID-19 , 2021, PloS one.

[7]  M. Billah,et al.  Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience , 2021, Journal of Infection and Public Health.

[8]  A. Seidler,et al.  The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis , 2021, BMJ Global Health.

[9]  A. Aminuddin,et al.  COVID-19 and Hypertension: The What, the Why, and the How , 2021, Frontiers in Physiology.

[10]  A. Mannan,et al.  A multi-centre, cross-sectional study on coronavirus disease 2019 in Bangladesh: clinical epidemiology and short-term outcomes in recovered individuals , 2021, New Microbes and New Infections.

[11]  M. Billah,et al.  An online observational study assessing clinical characteristics and impacts of the COVID-19 pandemic on mental health: a perspective study from Bangladesh , 2021, Journal of Public Health.

[12]  M. Nasir,et al.  Survival and Biomarkers of COVID-19 Patients Treated with Remdesivir and Favipiravir in ICU during the Peak of Pandemic: A Single Center Study in Bangladesh , 2021 .

[13]  Zhenyu Li,et al.  The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019 , 2020, EMBO molecular medicine.

[14]  M. Rahman,et al.  COVID-19 pandemic, socioeconomic crisis and human stress in resource-limited settings: A case from Bangladesh , 2020, Heliyon.

[15]  Ritesh Gupta,et al.  Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[16]  N. Bhardwaj,et al.  C-reactive protein as a prognostic marker of Plasmodiumfalciparum malaria severity , 2019, Journal of vector borne diseases.

[17]  A. Holland,et al.  Recovery Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease – A Review , 2019, COPD.

[18]  J. Carcillo,et al.  Hyperferritinemia and inflammation , 2017, International immunology.

[19]  C. Billington,et al.  Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet , 2017, Physiology & Behavior.

[20]  S. Takach Lapner,et al.  Review of D‐dimer testing: Good, Bad, and Ugly , 2017, International journal of laboratory hematology.

[21]  Y. Lim,et al.  Interaction of Vitamin D and Smoking on Inflammatory Markers in the Urban Elderly , 2015, Journal of preventive medicine and public health = Yebang Uihakhoe chi.

[22]  J. Foote,et al.  Smoking Status Effect on Inflammatory Markers in a Randomized Trial of Current and Former Heavy Smokers , 2015, International journal of inflammation.

[23]  L. Pączek,et al.  Inflammatory Markers Change with Age, but do not Fall Beyond Reported Normal Ranges , 2015, Archivum Immunologiae et Therapiae Experimentalis.

[24]  Jinyan Shao,et al.  Gender Differences in the Symptoms, Signs, Disease History, Lesion Position and Pathophysiology in Patients with Pulmonary Embolism , 2015, PloS one.

[25]  G. Yan,et al.  Serum CRP and urinary trypsin inhibitor implicate postoperative cognitive dysfunction especially in elderly patients , 2015, The International journal of neuroscience.

[26]  G. Sesti,et al.  Role of C Reactive Protein (CRP) in Leptin Resistance , 2014, Current pharmaceutical design.

[27]  L. Bathum,et al.  Age- and sex-dependent reference intervals for D-dimer: evidence for a marked increase by age. , 2013, Thrombosis research.

[28]  Y. Shoenfeld,et al.  The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome , 2013, BMC Medicine.

[29]  E. Arellano,et al.  C-Reactive Protein and Serum Amyloid A Overexpression in Lung Tissues of Chronic Obstructive Pulmonary Disease Patients: A Case-Control Study , 2013, International journal of medical sciences.

[30]  V. Master,et al.  Systematic Review of the Evidence of a Relationship Between Chronic Psychosocial Stress and C-Reactive Protein , 2013, Molecular Diagnosis & Therapy.

[31]  B. Cosmi,et al.  Age and gender specific cut-off values to improve the performance of d-dimer assays to predict the risk of venous thromboembolism recurrence , 2013, Internal and Emergency Medicine.

[32]  S. Berliner,et al.  C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection , 2010, BMC infectious diseases.

[33]  W. Koenig,et al.  CRP in Cardiovascular Disease , 2009, Herz.

[34]  V. Salomaa,et al.  Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study. , 2005, European heart journal.

[35]  A. Szalai C-Reactive Protein (CRP) and Autoimmune Disease: Facts and Conjectures , 2004, Clinical & developmental immunology.

[36]  M. Pepys C-reactive protein and the acute phase response , 1982, Nature.